"From routine appointments to emergency services, it’s important to get the care you need—when you need it. But we understand you may be delaying your health needs over concerns about safety. At Mount Sinai, our doctors, nurses, and staff members are working continuously to ensure your safety so that you don't have to put your health on hold."

During the past decade, Mount Sinai Chelsea conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Chelsea" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Chelsea" #1 collaborator was "NRG Oncology" with 10 trials as a collaborator, "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Chelsea" are "Stage IV Lung Cancer AJCC v8" (4 trials), "Anatomic Stage II Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Mount Sinai Chelsea" in a lesser frequency.

Most popular intervention types in "Mount Sinai Chelsea" are "Drug" (25 trials), "Procedure" (15 trials), "Radiation" (15 trials), "Other" (14 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (11 trials), "Computed Tomography" (10 trials), "Biospecimen Collection" (9 trials), "Carboplatin" (9 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Chelsea" are 21 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Mount Sinai Chelsea". undefined are not yet recruiting, 17 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Mount Sinai Chelsea, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Chelsea, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".